India: Patent’s defeat in India is key victory for generic drugs

The Indian Supreme Court rejected a Swiss drugmaker’s patent application for a major cancer drug on Monday in a landmark ruling that will allow poor patients continued access to many of the world’s best drugs, at least for a while.

Further reading